Projects funded by the NCN
Modification of the DNA helix structure by newly synthesized cytotoxic compound (Cl-IPBD) in selected cancer cell lines in the presence of antioxidants
2017/25/N/NZ7/00845
Keywords:
DNA anticancer drugs antioxidants cell lines
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Warszawski, Wydział Chemii
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: PRELUDIUM 13 - announced on 2017-03-15
Amount awarded: 120 000 PLN
Project start date (Y-m-d): 2018-01-10
Project end date (Y-m-d): 2021-01-09
Project duration:: 36 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
- Publication in academic press/journals (1)
- Differences in electrochemical response of prospective anticancer drugs IPBD and Cl-IPBD, doxorubicin and Vitamin C at plasmid modified glassy carbonAuthors:Dominika Janiszek, Monika M. Karpińska, Andrzej Niewiadomy, Anita Kośmider, Agnieszka Girstun, Hanna Elzanowska, Pawel J. KuleszaAcademic press:Bioelectrochemistry (rok: 2021, tom: 137, strony: 107682), Wydawca: ElsevierStatus:PublishedDOI:10.1016/j.bioelechem.2020.107682 - link to the publication